Physician profile
Gabriel E Soto
NPI 1528148491
$39,447.32
in general payments reported to CMS, 2019-2025
41 companies · $9,080 in 2025
The $9,080 reported for 2025 was more than what 78% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,528 · 2020: $2,029 · 2021: $4,267 · 2022: $5,335 · 2023: $6,855 · 2024: $10K · 2025: $9,080.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Travel and Lodging: $6,784 · Consulting Fee: $3,540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,964.87 |
| Travel and Lodging | $6,784.00 |
| Consulting Fee | $3,539.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $18,084.79 | 2019-2025 | Aveir, Ensite, Amplatzer Amulet |
| Medtronic, INC. | $6,485.61 | 2021-2025 | Micra, Evera Mri Xt Dr Surescan, Aurora Ev-Icd Mri Surescan |
| Merit Medical Systems INC | $4,279.50 | 2025 | Flextract |
| Biosense Webster, INC. | $2,084.16 | 2022-2025 | Carto 3, Qdot Micro Catheter, Qdot Micro |
| Terumo Medical Corporation | $1,900.00 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $1,458.35 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $778.64 | 2023-2025 | Vigilant X4 Crt-D, Ingevity+, Rhythmia Mapping System |
| Astrazeneca Pharmaceuticals LP | $447.75 | 2021-2023 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $389.99 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $371.72 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $356.68 | 2019-2023 | Jardiance |
| Amgen INC. | $344.88 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $344.42 | 2024 | Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $335.58 | 2019-2025 | Lifevest |
| Cook Medical LLC | $219.08 | 2022-2024 | Evolution |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $197.61 | 2021-2023 | Dupixent |
| Sanofi-Aventis U.S. LLC | $185.13 | 2022-2024 | |
| Atricure, INC. | $183.32 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Heartflow, INC. | $146.86 | 2024 | |
| Merck Sharp & Dohme LLC | $103.66 | 2022-2024 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $93.17 | 2022-2023 | Opsumit |
| Baxter Healthcare | $87.45 | 2023 | Actifuse, Hillrom - Life 2000 Ventilation System |
| Astellas Pharma US INC | $82.99 | 2019 | |
| Irhythm Technologies, INC. | $77.49 | 2019-2024 | Zio Xt Patch |
| Jazz Pharmaceuticals INC. | $69.46 | 2021-2023 | |
| Elutia, INC. | $51.74 | 2021 | |
| Cardiva Medical, INC. | $30.04 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f, Ensoetm |
| Cvrx, INC. | $29.47 | 2023 | Barostim Neo System |
| Itamar Medical INC | $26.80 | 2025 | Watchpatone |
| United Therapeutics Corporation | $21.16 | 2023 | Tyvaso |
| Bayer Healthcare Pharmaceuticals INC. | $20.31 | 2022 | |
| Inspire Medical Systems, INC. | $19.17 | 2023 | Inspire |
| Livanova USA, INC. | $18.07 | 2019 | |
| Medtronic Vascular, INC. | $18.00 | 2020 | |
| Mallinckrodt Hospital Products INC. | $16.67 | 2022 | |
| Amarin Pharma, INC. | $16.66 | 2021 | |
| Cordis US Corp. | $16.03 | 2024 | Mynx Venous Vcd |
| Pfizer INC. | $15.09 | 2024 | |
| Chiesi USA, INC. | $14.58 | 2024 | Kengreal, Cleviprex |
| Angiodynamics, INC. | $13.59 | 2019 | |
| Edwards Lifesciences Corporation | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabriel Soto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.